Professor | Xi Ming Xu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Xi Ming Xu
Contact Information	doctorxu120@aliyun.com
Language ability	Chinese, English
Province	Hubei

Upload Avatar (500 x 500)

Name

Xi Ming Xu

Contact Information

doctorxu120@aliyun.com

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1995-2000: Bachelor of Clinical Medicine, Xianning Medical College 2000-2003: Master of Internal Medicine, Wuhan University 2003-2006: PhD in Internal Medicine, Wuhan University Hosted multiple national and provincial research projects Published over 50 research papers
Work Experience	2006-2007: Attending Physician, Oncology Center, Renmin Hospital of Wuhan University 2008-2012: Deputy Chief Physician, Master's Supervisor, Oncology Center, Renmin Hospital of Wuhan University 2009-2010: Postdoctoral Fellow in Oncology, University of Georgia, USA 2013-2019: Chief Physician, Associate Professor, Master's Supervisor, Department of Oncology III, Renmin Hospital of Wuhan University 2020: Chief Physician, Associate Professor, Doctoral Supervisor, Department of Oncology III, Renmin Hospital of Wuhan University
Awards	2022: First Prize of Hubei Provincial Science and Technology Progress Award 2022: Model of Medical Ethics, Wuhan University 2014: Third Prize of Scientific and Technological Progress of Hubei Province

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1995-2000: Bachelor of Clinical Medicine, Xianning Medical College
2000-2003: Master of Internal Medicine, Wuhan University
2003-2006: PhD in Internal Medicine, Wuhan University
Hosted multiple national and provincial research projects
Published over 50 research papers

Work Experience

2006-2007: Attending Physician, Oncology Center, Renmin Hospital of Wuhan University
2008-2012: Deputy Chief Physician, Master's Supervisor, Oncology Center, Renmin Hospital of Wuhan University
2009-2010: Postdoctoral Fellow in Oncology, University of Georgia, USA
2013-2019: Chief Physician, Associate Professor, Master's Supervisor, Department of Oncology III, Renmin Hospital of Wuhan University
2020: Chief Physician, Associate Professor, Doctoral Supervisor, Department of Oncology III, Renmin Hospital of Wuhan University

Awards

2022: First Prize of Hubei Provincial Science and Technology Progress Award
2022: Model of Medical Ethics, Wuhan University
2014: Third Prize of Scientific and Technological Progress of Hubei Province

Areas of Focus	Pathogenesis of liver cancer Radioresistance mechanisms in cancer Metastasis mechanisms in cancer Clinical treatment of liver cancer
Publications	The application of nanoparticles in immunotherapy for hepatocellular carcinoma, Hu X, Zhu H, He X, Chen J, Xiong L, Shen Y, Li J, Xu Y, Chen W, Liu X, Cao D, Xu X, 2023 Global microarray profiling identified hsa_circ_0064428 as a potential immune-associated prognosis biomarker for hepatocellular carcinoma, Weng Q, Chen M, Li M, Zheng YF, Shao G, Fan W, Xu XM, Ji J, 2019 Immune checkpoint modulators in cancer immunotherapy: Recent advances and combination rationales, Fan L, Li Y, Chen JY, Zheng YF, Xu XM, 2019 T cell dysfunction in chronic hepatitis B infection and liver cancer: evidence from transcriptome analysis, Wang YG, Zheng DH, Shi M, Xu XM, 2019 MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis, Zhang X, He X, Li Y, Xu Y, Chen W, Liu X, Hu X, Xiong L, Xu X, 2021 Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m(6)A RNA Methylation Regulators in Hepatocellular Carcinoma, Xu Y, He X, Deng J, Xiong L, Li Y, Zhang X, Chen W, Liu X, Xu X, 2021 Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma, Li Y, He X, Zhang X, Xu Y, Wu Y, Xu X, 2021 RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma, Li Y, He X, Zhang X, Xu Y, Chen W, Liu X, Xu X, 2021 Identification of a novel immune prognostic model in gastric cancer, Li Y, He X, Fan L, Zhang X, Xu Y, Xu X*, 2021

Areas of Focus

Pathogenesis of liver cancer
Radioresistance mechanisms in cancer
Metastasis mechanisms in cancer
Clinical treatment of liver cancer

Publications

The application of nanoparticles in immunotherapy for hepatocellular carcinoma, Hu X, Zhu H, He X, Chen J, Xiong L, Shen Y, Li J, Xu Y, Chen W, Liu X, Cao D, Xu X*, 2023
Global microarray profiling identified hsa_circ_0064428 as a potential immune-associated prognosis biomarker for hepatocellular carcinoma, Weng Q, Chen M, Li M, Zheng YF, Shao G, Fan W, Xu XM*, Ji J, 2019
Immune checkpoint modulators in cancer immunotherapy: Recent advances and combination rationales, Fan L, Li Y, Chen JY, Zheng YF, Xu XM*, 2019
T cell dysfunction in chronic hepatitis B infection and liver cancer: evidence from transcriptome analysis, Wang YG, Zheng DH, Shi M, Xu XM*, 2019
MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis, Zhang X, He X, Li Y, Xu Y, Chen W, Liu X, Hu X, Xiong L, Xu X*, 2021
Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m(6)A RNA Methylation Regulators in Hepatocellular Carcinoma, Xu Y, He X, Deng J, Xiong L, Li Y, Zhang X, Chen W, Liu X, Xu X*, 2021
Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma, Li Y, He X, Zhang X, Xu Y, Wu Y, Xu X*, 2021
RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma, Li Y, He X, Zhang X, Xu Y, Chen W, Liu X, Xu X*, 2021
Identification of a novel immune prognostic model in gastric cancer, Li Y, He X, Fan L, Zhang X, Xu Y, Xu X*, 2021

Liver Cancer Pathogenesis Radioresistance Metastasis Clinical Treatment Oncology Cancer Therapy Tumor Immunotherapy Targeted Therapy

Jianyang Hu - Southern University of Science and Technology

Lin Congyao - Wuhan University

Hai-Xia Ding - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us